Nuclear Pharmacy Practice
Conference (Saturday Only) – Pharmacists

Nuclear Pharmacy Practice <br>Conference (Saturday Only) – Pharmacists

Nuclear Pharmacy Practice
Conference (Saturday Only) – Pharmacists

Nuclear Pharmacy Practice Conference (Saturday Only) - Pharmacists

 

Saturday, October 7, 2023

Pharmacy and Therapeutics Formulary Process, A Case Study on Sincalide

8:00am-9:30am 

Jacob Haddock, PharmD, ANP, Oklahoma University Medical Center, Clinical Pharmacist

Upon completion of this activity, pharmacists will be able to: Describe the function and oversight of the pharmacy and therapeutics (P&T) committee; Provide information required by the pharmacy director to add a generic to the formulary; Evaluate a medication for inclusion in the formulary using the example provided.

UAN: 0675-0000-23-017-L04-P

 

Primer on Potential Theragnostic Agents

9:30am-11:00am 

Wendy Galbraith, PharmD, FAPhA, BCNP, Clinical Associate Professor, University of Oklahoma, Dept. of Pharmaceutical Sciences, College of Pharmacy, Nuclear Pharmacy & Research Imaging Facility

Upon completion of this activity, pharmacists will be able to: Recall radionuclides for therapy; Describe regulations for therapy radiopharmaceuticals; Identify new radiopharmaceutical therapies in the pipeline.

UAN: 0675-0000-23-018-L04-P

 

Nuclear Pharmacy:  Departments Questions when 795, 797, and 825 are Official – PART 1   

11:15am-12:45pm 

Jessica Comstock, PharmD, BCNP, Vice President Pharmacy Quality and Regulatory, PharmaLogic Holdings

Upon completion of this activity, pharmacists will be able to: Describe the changes taking place with the implementation of USP 825, 797, and 795; Identify the additional USP chapters that are applicable to nuclear pharmacy; Describe how internal procedures and parameters are determined and why they matter.

UAN: 0675-0000-23-019-L07-P

 

Sterile Preparation of I-131 Solution for Feline Hyperthyroidism

12:45pm-2:15pm 

Garcia Simon, PharmD, MS, ANP, CCP, BCNP, Kindred Healthcare, Pharmacy Supervisor

Upon completion of this activity, pharmacists will be able to: Describe the treatments available for feline hyperthyroidism; Identify the methods of administration of I-131 solution; Discuss the preparation method of the sterile solution applying principles of radiation safety.

UAN: 0675-0000-23-020-L01-P

 

 

No Comments

Comments are closed.